Hari Krishna K, Meghana B, Mercia Rani G, Anitha K, Jagadeesh A, Jalaiah M
{"title":"Treatment and management of rheumatoidarthritis","authors":"Hari Krishna K, Meghana B, Mercia Rani G, Anitha K, Jagadeesh A, Jalaiah M","doi":"10.37022/jiaps.v8i3.515","DOIUrl":null,"url":null,"abstract":"Rheumatoid arthritis is an autoimmune inflammatory disease characterized mostly by synovitis, which is frequently Clinical manifestations include fever, malaise, edema, pain, and stiffness in several joints are followed with extra-articular organ involvement, such as interstitial pneumonia. After the initial stage, joint degradation progresses swiftly, and once the afflicted areas' deformed joints are obvious, physical dysfunction that cannot be reversed begins to occur. Thus, precise diagnosis and Treatment is required from the moment the problem first appears. While anti-inflammatory drugs and glucocorticoids were used as palliative care, disease-modifying anti-rheumatic drugs (DMARDs) are currently used to slow down and control the advancement of sickness and immunological diseases. By maintaining remission, these drugs have also been shown to halt the advancement of joint degradation and physical disability over a prolonged period of time. Precision medicine, safer and more effective treatment techniques targeted at drug holidays or cures, and therapeutic strategies are some of the future developments in medicine.","PeriodicalId":151037,"journal":{"name":"Journal of Innovations in Applied Pharmaceutical Science (JIAPS)","volume":"51 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Innovations in Applied Pharmaceutical Science (JIAPS)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37022/jiaps.v8i3.515","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Rheumatoid arthritis is an autoimmune inflammatory disease characterized mostly by synovitis, which is frequently Clinical manifestations include fever, malaise, edema, pain, and stiffness in several joints are followed with extra-articular organ involvement, such as interstitial pneumonia. After the initial stage, joint degradation progresses swiftly, and once the afflicted areas' deformed joints are obvious, physical dysfunction that cannot be reversed begins to occur. Thus, precise diagnosis and Treatment is required from the moment the problem first appears. While anti-inflammatory drugs and glucocorticoids were used as palliative care, disease-modifying anti-rheumatic drugs (DMARDs) are currently used to slow down and control the advancement of sickness and immunological diseases. By maintaining remission, these drugs have also been shown to halt the advancement of joint degradation and physical disability over a prolonged period of time. Precision medicine, safer and more effective treatment techniques targeted at drug holidays or cures, and therapeutic strategies are some of the future developments in medicine.